Literature DB >> 7516935

Alterations in tau immunostaining in the rat hippocampus following transient cerebral ischemia.

J W Geddes1, C Schwab, S Craddock, J L Wilson, L C Pettigrew.   

Abstract

Previous studies in gerbils have shown that cytoskeletal disruption and a loss of the dendritic microtubule-associated protein, MAP2, may occur after short periods of transient global ischemia. tau, a predominantly axonal microtubule-associated protein, has not been examined following ischemia. We compared neuronal damage with alterations in MAP2, tau, and 72-kD heat shock protein (HSP72) immunostaining at various reperfusion times following 20 min of ischemia in the rat four-vessel occlusion model. tau accumulated in neuronal cell bodies throughout the hippocampal formation 30 min to 2 h after the ischemic insult. Perikaryal tau immunostaining was transient in most regions, but persisted in polymorphic hilar neurons. This was accompanied by a loss of immunostaining in the target of many hilar neurons, the inner molecular layer of the dentate gyrus. The same neuronal populations that exhibited increased tau immunostaining of perikarya later displayed an induction of HSP72 immunoreactivity. In contrast, loss of MAP2 immunostaining was not consistently observed before neuronal death and did not correspond to HSP72 induction. The altered tau immunostaining is not the direct result of excitotoxic insult, as intrahippocampal injection of kainic acid did not cause the somal accumulation of tau, but did cause disruption of MAP2 immunostaining. Taken together, the results suggest that the somal accumulation of tau is an early, sensitive, and selective marker of ischemic insult.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7516935     DOI: 10.1038/jcbfm.1994.69

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  22 in total

1.  Ischemic preconditioning attenuates of ischemia-induced degradation of spectrin and tau: implications for ischemic tolerance.

Authors:  Takayuki Nakajima; Syoichi Ochi; Chika Oda; Maki Ishii; Kazushige Ogawa
Journal:  Neurol Sci       Date:  2010-07-02       Impact factor: 3.307

2.  Differential changes in phosphorylation of tau at PHF-1 and 12E8 epitopes during brain ischemia and reperfusion in gerbils.

Authors:  W Gordon-Krajcer; E Kozniewska; J W Lazarewicz; H Ksiezak-Reding
Journal:  Neurochem Res       Date:  2006-12-27       Impact factor: 3.996

3.  Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism.

Authors:  E Rundén; P O Seglen; F M Haug; O P Ottersen; T Wieloch; M Shamloo; J H Laake
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

4.  Presenilin-1 regulates the neuronal threshold to excitotoxicity both physiologically and pathologically.

Authors:  M Grilli; E Diodato; G Lozza; R Brusa; M Casarini; D Uberti; R Rozmahel; D Westaway; P St George-Hyslop; M Memo; E Ongini
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

5.  Human tau becomes phosphorylated and forms filamentous deposits when overexpressed in lamprey central neurons in situ.

Authors:  G F Hall; J Yao; G Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

6.  Quantitative analysis of MAP2 immunoreactivity in human neocortex of three patients surviving after brain ischemia.

Authors:  Victor A Akulinin; Annica Dahlstrom
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

7.  Stress-induced tau phosphorylation in mouse strains with different brain Erk 1 + 2 immunoreactivity.

Authors:  A Y Korneyev
Journal:  Neurochem Res       Date:  1998-12       Impact factor: 3.996

8.  Early glycogen synthase kinase-3β and protein phosphatase 2A independent tau dephosphorylation during global brain ischaemia and reperfusion following cardiac arrest and the role of the adenosine monophosphate kinase pathway.

Authors:  Shohreh Majd; John H T Power; Simon A Koblar; Hugh J M Grantham
Journal:  Eur J Neurosci       Date:  2016-06-08       Impact factor: 3.386

Review 9.  Dementia, Preclinical Studies in Neurodegeneration and its Potential for Translational Medicine in South America.

Authors:  Gloria Patricia Cardona-Gómez; Francisco Lopera
Journal:  Front Aging Neurosci       Date:  2016-12-20       Impact factor: 5.750

Review 10.  Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes.

Authors:  Ryszard Pluta; Mirosław Jabłoński; Marzena Ułamek-Kozioł; Janusz Kocki; Judyta Brzozowska; Sławomir Januszewski; Wanda Furmaga-Jabłońska; Anna Bogucka-Kocka; Ryszard Maciejewski; Stanisław J Czuczwar
Journal:  Mol Neurobiol       Date:  2013-03-22       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.